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Abstract
Four totally conserved glycines are involved in the packing of the two cytochrome b hemes, bL and bH, of the bc1 complex.
The conserved glycine 131 is involved in the packing of heme bL and is separated by only 3 Aî from this heme in the bc1
complex structure. The cytochrome b respiratory deficient mutant G131S is affected in the assembly of the bc1 complex. An
intragenic suppressor mutation was obtained at position 260, in the ef loop, where a glycine was replaced by an alanine. This
respiratory competent revertant exhibited a low bc1 complex activity and was affected in the electron transfer at the QP site.
The kmin for the substrate DBH2 was diminished by an order of magnitude and EPR spectra showed a partially empty QP
site. However, the binding of the QP site inhibitors stigmatellin and myxothiazol remained unchanged in the suppressor
strain. Optical spectroscopy revealed that heme bL is red shifted by 0.8 nm and that the Em of heme bL was slightly increased
(+20 mV) in the revertant strain as compared to wild type strain values. Addition of a methyl group at position 260 is thus
sufficient to allow the assembly of the bc1 complex and the insertion of heme bL despite the presence of the serine at position
131. Surprisingly, reversion at position 260 was located 13 Aî away from the original mutation and revealed a long distance
interaction in the yeast bc1 complex. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The cytochrome bc1 complex (known as the b6f
complex in chloroplasts and cyanobacteria) is a key
component of the respiratory and photosynthetic
electron transfer chains (see [1^3] for reviews). It is
present in the cytoplasmic membrane of bacteria and
in the inner mitochondrial membrane of eukaryotes
and catalyzes the oxidation of hydroquinone linked
to the reduction of cytochrome (cyt) c. This electron
transfer is coupled to a vectorial translocation of
protons across the membrane and is best described
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Abbreviations: cyt, cytochrome; bL, low potential cyt b heme;
bH, high potential cyt b heme; DB, 2,3-dimethoxy-5-methyl-6-
decyl-1,4-benzoquinone; DBH2, reduced form of DB; QP, ubi-
quinol oxidation site on the positive side of the inner mitochon-
drial membrane; QN, ubiquinone reduction site on the negative
side; EPR, electron paramagnetic resonance; Eh, ambient redox
potential ; Em, equilibrium redox midpoint potential ; WT, paren-
tal strain
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by the Q cycle mechanism [4^6]. All bc1 complexes,
from bacteria to higher eukaryotes, contain three
subunits carrying four prosthetic groups: a monohe-
mic cyt c1, a FeS Rieske protein with a [2Fe^2S]
cluster, a dihemic cyt b with a low potential bL
heme (Em;7 =350 mV) located on the positive side
of the membrane and a high potential bH heme
(Em;7 = +90 mV) located on the negative side of the
membrane. In eukaryotic cells, in addition to these
three totally conserved subunits, as many as eight
additional subunits are found whose functions are
poorly understood [7].
Several three-dimensional structures of eukaryotic
bc1 complexes have been obtained in the past few
years in the presence or absence of di¡erent inhibi-
tors [8^11]; this allows combined functional and
structural analyses of mutants and revertants in the
bc1 complex subunits. Analyses of the di¡erent struc-
tures suggest that the extrinsic domain of the FeS
Rieske protein carrying the [2Fe^2S] cluster may
undergo a rotation between a position close to cyto-
chrome b (proximal conformation or b state) and a
position close to cytochrome c1 (distal conformation
or c1 state), thus providing a rational explanation for
the incompatibility of the distances and the rate of
electron transfer between the redox centers [8^11].
Results obtained from mutagenesis experiments
have con¢rmed this hypothesis [12^15]. Very re-
cently, Hunte et al. solved the bc1 complex structure
of the yeast Saccharomyces cerevisiae at 2.3 Aî , in-
cluding water molecules [16]. Cytochrome b is an
integral membrane protein with eight transmembrane
helices and is a central component for quinol oxida-
tion and inhibitor binding. According to the modi-
¢ed Q cycle [4^6,17], electrons are delivered into two
bifurcated pathways at the QP site (on the positive
side of the membrane): the ¢rst electron from quinol
is transferred to the FeS Rieske protein (in the so-
called high potential electron transfer pathway to cyt
c1 and the soluble cyt c) resulting in the formation of
an unstable semiquinone which then transfers the
second electron to hemes bL and bH (in the so-called
low potential pathway) across the membrane. At the
QN site, on the negative side of the membrane, qui-
none is reduced to semiquinone. Two molecules of
ubiquinol at the QP site are thus required to reduce a
quinone to quinol at the QN site. Several mechanistic
models have been proposed on the basis of the Q
cycle to account for the bifurcated electron transfer
at the QP site [18^23].
Four totally conserved histidines are axial ligands
for hemes bL and bH, and are located in the trans-
membrane helices B and D. Additionally, Tron et al.
[24] proposed that four totally conserved glycines,
present in the transmembrane helices A (glycines 33
and 47) and C (glycines 117 and 131) and separated
by 13 amino acids in each helix (such as is the case of
the four histidine ligands), may be important in the
packing of hemes bL and bH. This proposal has been
con¢rmed by analysis of the mitochondrial bc1 com-
plexes structures [8^10], in which the four glycines
are symmetrically positioned close to either bL or
bH hemes. Mutants of two of these glycines have
been obtained at position G33 (yeast numbering) in
both S. cerevisiae [25,26] and Rhodobacter sphae-
roides [27], as well as at position G131 in S. cerevisiae
[28] and Rhodobacter capsulatus [29]. Rather small
amino acids, such as glycine or alanine, are required
at these positions to allow correct assembly and
function of the complex. Thus, glycines have been
shown to be crucial in the packing of hemes bL
and bH. The conserved glycine 131 is separated by
only 3 Aî from heme bL in the bovine bc1 complex
structure.
In the present study, we investigated the possibility
of obtaining second site suppressor mutations from
the G131S mutant and undertook the biochemical
and biophysical characterization of such a revertant.
From the respiratory de¢cient mutant G131S, which
has a bc1 complex with an assembly defect, only one
intragenic suppressor mutation distinct from the wild
type glycine was found at position 260, in the ef
loop, where a glycine was replaced by an alanine.
This revertant restored the assembly of the bc1 com-
plex but exhibited a low bc1 complex activity. It was
shown to be a¡ected mainly at the QP site, with a
modi¢ed interaction with the substrate quinol. Sur-
prisingly, reversion in position 260 occurred 13 Aî
away from the original mutation in position 131.
This study reveals, for the ¢rst time, that a mutation
at one of the totally conserved glycines at the end of
the transmembrane helix C can be compensated by a
long distance suppressor mutation in the non-trans-
membrane ef loop of cyt b. These results will be
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presented with respect to the bc1 complex structure
and a possible explanation for this long distance in-
teraction will be discussed.
2. Materials and methods
2.1. Strains
The original rho mit3 cytochrome b de¢cient mu-
tant 777-3A/W7 was obtained from the Gif collec-
tion. It was isolated from the haploid strain rho
mit 777-3A, K op1 ade1 [30] and its mtDNA se-
quence revealed that the cyt b glycine 131 was re-
placed by a serine [28]. The nuclear recessive op1
mutation impairs ATP/ADP translocation, which
leads to an inability to grow on respiratory sub-
strates, even in the presence of a functional respira-
tory chain [31]. Therefore the parental strain 777-3A
K op1 ade1 rho mit and mutant W7 were crossed
with the rho0 strain KL14-4A a his1 trp2 OP1, which
possesses the wild type allele of the op1 mutation. All
the experiments were carried out on diploid strains
that were isogenic, with the exception of the cyto-
chrome b mutations. Isolation of respiratory compe-
tent revertants was as described in [32].
2.2. Medium, growth conditions, in vivo phosphoryla-
tion e⁄ciency and preparation of mitochondria
The growth medium contained 2% yeast extract
(Difco), 1% bacto-peptone (Difco), 0.12% ammo-
nium sulfate and 2% galactose as the energy source.
1 ml of preculture was used to inoculate toxin £asks
containing 500 ml of medium vigorously shaken at
28‡C and harvested 48 h later (beginning of the sta-
tionary phase), as described previously [33]. Growth
yield, phosphorylation e⁄ciency and growth rate
were determined as outlined in [34] and [35]. Prepa-
ration of mitochondria was performed according to
the mechanical method of Guerin et al. [36] with
slight modi¢cation [33].
2.3. Activities of the whole respiratory chain and of its
various segments
All the respiratory activities were carried out on
isolated mitochondria. For the whole chain, they
were as described by Meunier-Lemesle et al. [33] in
the MR3 bu¡er (0.65 M sorbitol, 10 mM KH2PO4,
2 mM EDTA, 0.1 mM MgCl2, 0.3% bovine serum
albumin, pH 6.5). The various segment activities de-
scribed below were measured at 25‡C in phosphate
bu¡er (50 mM potassium phosphate, 50 WM EDTA,
pH 7.4), using the dual wavelength-stirred reaction
cuvette procedure [37]. NADH-ubiquinone reductase
activity (segment I) was measured spectrophotomet-
rically by following NADH (0.5 mM) oxidation
monitored at the 340/425 nm wavelength pair with
DB (0.1 mM) as quinone electron acceptor, in the
presence of 2 mM KCN. Complex II activity (succi-
nate-ubiquinone reductase) was measured by DB re-
duction at 280/325 nm with saturating amounts of
succinate (10 mM) as electron donor, in the presence
of 2 mM KCN. Complex III, or DBH2-cytochrome c
reductase activity, was determined by measuring the
reduction of cytochrome c (40 WM) at 550 nm using
540 nm as a reference in the presence of KCN (2
mM) with decylubiquinol (50 WM DBH2) as electron
donor. The I50 value for inhibitors is de¢ned as the
concentration required to reduce the DBH2-cyt c re-
ductase activity by 50% and is expressed in moles of
inhibitor per mole of cyt b content for each strain.
The relative inhibitor titer Ir50 is the ratio between the
I50 in a mutated strain and I50 obtained with the wild
type strain and indicates the resistance of a strain to
the inhibitor in comparison with the wild type strain
[38]. The combined activities of segment I+III
(NADH-cyt c reductase) or II+III (succinate-cyt c
reductase) were measured by monitoring the reduc-
tion of cyt c at 550/540 nm with NADH or succinate
as electron donor, in the presence of 2 mM KCN.
Extinction coe⁄cients of 6.22, 16, 18, and 24 mM31
cm31 were used for calculations of NADH, DB, cyt
c+c1 and cyt b, respectively.
2.4. Spectral analysis
Optical absorption spectra at room temperature
were obtained as described previously [33]. Low tem-
perature spectra were recorded at liquid nitrogen
temperature (77 K) using a dual wavelength
DW2000 SLM-Aminco spectrophotometer with a
slit of 0.2^0.4 nm. Wavelengths were calibrated
with a Holmium ¢lter, and the spectra of membranes
suspended in MR3 bu¡er were recorded.
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2.5. Redox titrations
Optical redox titrations were carried out at 25‡C
as described by Dutton [39], with a £ow of argon
gas, using a dual wavelength DW2000 SLM-Aminco
spectrophotometer. Reductive and oxidative titra-
tions were conducted with sodium dithionite and po-
tassium ferricyanide, respectively. Mitochondria were
suspended in 50 mM MOPS bu¡er, pH 7. The fol-
lowing redox mediators were used at a ¢nal con-
centration of 5 WM: potassium ferricyanide, ferro-
cenemonocarboxylic acid, 1,4-benzoquinone, 2,5-
dimethyl-p-benzoquinone, 1,2-naphthoquinone, phe-
nazine methosulfate, tetramethyl-p-benzoquinone,
2-methyl-1,4-naphthoquinone, 2,5-dihydroxy-p-ben-
zoquinone, indigo carmine, 2-hydroxy-1,4-naphtho-
quinone, anthraquinone-2,6-disulfonate, and anthra-
quinone-2-sulfonate.
2.6. Presteady-state cytochrome reduction kinetics by
the center P and center N pathways
Cyt b reduction kinetics were monitored at 562 nm
using 575 nm as a reference with a dual wavelength
Aminco DW2A spectrophotometer equipped with a
rapidly stirred reaction cuvette, as described by Bras-
seur et al. [37]. NADH (2 mM) or succinate (25 mM)
was used as electron donor. Antimycin (20 WM) or
myxothiazol (30 WM) was used at saturating levels to
observe the center P and center N cyt b reduction
kinetics, respectively; the ‘double kill’ was observed
when both inhibitors were added (results not shown).
Cytochrome c+c1 reduction kinetics by the high po-
tential electron transfer pathway were recorded at
551/540 nm with NADH as electron donor in the
presence of 2 mM KCN [40].
2.7. EPR spectra
EPR spectra were recorded at liquid helium tem-
perature on a Bruker ESP 300E X-band spectrometer
equipped with an Oxford Instruments liquid helium
cryostat and temperature control system. Mitochon-
dria were suspended in 0.65 M sorbitol, 10 mM Tris^
HCl, 2 mM EDTA, 0.1% bovine serum albumin, pH
6.5.
2.8. Molecular representation
Molecular representation was carried out using the
Swiss-Pdb Viewer software [41] available on the Web
(http://www.expasy.ch/spdbv/). The X-ray coordi-
nates of the chicken heart mitochondrial bc1 complex
in the presence of the stigmatellin inhibitor [9] (ac-
cession No. 3bcc in the Brookhaven Protein Data
Bank) were used to visualize the regions of cyto-
chrome b described in this study and to calculate
the closest distances between selected atoms.
2.9. Chemicals
Inhibitors were used in the form of stock ethanolic
or dimethyl sulfoxide (Me2SO) solutions. Antimycin
and decylubiquinone were obtained from Sigma,
myxothiazol from Boehringer and stigmatellin from
Fluka. All other chemicals were reagent grade and
were purchased from commercial sources.
3. Results
3.1. Characterization of the strains
Non-native intragenic revertant G131S+G260A
had been selected from the original cyt b respiratory
de¢cient mutant G131S. Whereas the mutant G131S
is unable to grow on respiratory substrates (glycerol
or ethanol, Table 1), the revertant G131S+G260A is
able to grow on these substrates but with a much
longer doubling time than that of the wild type strain
(19 h and 3 h 5 min on ethanol for the revertant and
wild type strain, respectively). In addition to a lower
growth rate, the suppressor strain showed a lower
growth yield on respiratory substrate ethanol (69%
compared to the wild type value). The respiratory
de¢cient mutant G131S grew only by fermentation
and exhibited on galactose a lower growth yield
(16%) and a higher doubling time (3 h) than the
wild type strain (1 h 40 min). The suppressor strain
exhibited an intermediate phenotype on galactose
with a doubling time of 2 h 15 min and a growth
yield of 66% (Table 1), which is in agreement with it
being a respiratory competent strain.
Table 1 gives the values of the cytochrome content
for the di¡erent strains. The results show that the
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revertant strain G131S+G260A recovered about 70%
of the total dithionite spectral cyt b compared to the
wild type strain, whereas the original mutant G131S
exhibited only about 25% of total cyt b. The original
mutant G131S and its revertant were shown to con-
tain about the same quantity of dithionite reducible
cytochromes c+c1 (about 70% compared to the wild
type value). No signi¢cant di¡erence was observed in
the synthesis of cyt aa3 between the di¡erent strains
tested. Whereas the bc1 complex of the cyt b mutant
G131S was not properly assembled (cyt b and core
protein I de¢cient [42]), the revertant strain exhibited
about 70% of spectral bc1 complex in the mitochon-
drial membrane compared to the wild type strain.
3.2. Enzymatic activities in the various segments of
the respiratory chain and in the whole chain
Table 2 shows that the succinate oxidase activity
was nil in the G131S mutant and amounted to only
17% in the suppressor strain as compared to the wild
type strain activity. Succinate and NADH-cyt c re-
ductase activities were nil in the original mutant and
attained 26% and 11% in the revertant strain, respec-
tively. As segment I and complex II activities were
not drastically modi¢ed in this revertant strain
(about 100% and 70%, respectively (Table 2)), the
defect must be mainly localized at the bc1 complex
level. Indeed, the DBH2-cyt c reductase activity was
Table 1
Growth characteristics on respiratory and fermentable substrates, and cytochrome content in the respiratory de¢cient mutant G131S,
in the suppressor mutant G131S+G260A and in the wild type strain
Strains Growth on
respiratory
substrates
(glycerol,
EtOH)
Doubling
time on
EtOH
Phospho-
rylation
e⁄ciency
on EtOH
Doubling
time on
galactose
Phosphor-
ylation
e⁄ciency on
galactose
Cytochrome content
c+c1 b a+a3
Wild type
(KM91)
GLY 3 h 5 min 100 1 h 40 min 100 100 100 100
G131S GLY3 ^ ^ 3 h 15.8 74 25 96
G131S+G260A GLY 19 h 69 2 h 15 min 66 68 71 118
Growth on respiratory (2% EtOH, 2% glycerol) and fermentable (2% galactose) substrates was checked on plates and the doubling
time was measured on liquid medium. The phosphorylation e⁄ciency (moles ATP synthesized/mole substrate consumed) was calcu-
lated as in [34]. Cytochrome content is expressed as a percentage relative to that found in the wild type. For the wild type strain, total
dithionite reduced cytochrome c+c1, b and a+a3 contents are 0.56, 0.46 and 0.14 nmol/mg protein, respectively. Values are expressed
as averages based on several experiments.
Table 2
Succinate oxidase activity, succinate- and NADH-cyt c reductase activities and activities of the di¡erent segments of the respiratory
chain
Strains Succinate oxidase Succinate-cyt c NADH-cyt c Segment I
NADH-DB
Complex II
succinate-DB
Complex III
DBH2-cyt c
Activity T.N.
Wild type 100 100 100 100 100 100 100
G131S 0 0 0 57 6 0 0
G131S+G260A 17 26 11 97 69 11 15
All activities are expressed as percentages of the wild type values. Segment I is used instead of complex I as there is no phosphoryla-
tion site associated with NADH-ubiquinone reductase activity in S. cerevisiae [43,44]. With the wild type strain, the values obtained
were: succinate oxidase, 0.076 Wmol O2 min31 mg31 ; succinate-cyt c reductase, 0.24 Wmol cyt c reduced min31 mg31 ; NADH-cyt c re-
ductase, 0.50 Wmol cyt c reduced min31 mg31 ; segment I (NADH-DB reductase), 1.48 Wmol NADH oxidized min31 mg31 ; complex
II (succinate-DB reductase), 0.25 Wmol DB reduced min31 mg31 ; complex III (DBH2-cyt c reductase), 0.85 Wmol cyt c reduced min31
mg31 ; complex III turnover number (T.N.), 62 s31. Values are expressed as averages based on several experiments.
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decreased by approx. 90% in the suppressor strain,
although this low activity was enough to sustain a
slow growth on respiratory substrates, indicating
that the proton translocation associated with this
electron transfer is su⁄cient. The complex II activity
of the respiratory de¢cient mutant G131S was found
to be less than 10% compared to the wild type strain,
as has already been observed in the case of other
respiratory de¢cient cyt b mutants [37,45]. This
may be due to a close interaction between the bc1
and succinate-quinone reductase complexes, as pro-
posed by Bruel et al. [46].
3.3. Optical spectrum analysis of the cyt bL and
bH hemes in the suppressor and wild type strains
Optical spectra were recorded at room temperature
(data not shown) and at liquid nitrogen temperature
to enhance the resolution of the peaks. Insofar as
heme bH is concerned, no di¡erence was observed
in the revertant strain compared to the wild type
strain (Fig. 1A). Conversely, heme bL was shifted
towards the red by 0.8 nm ( þ 0.1 nm) in the suppres-
sor strain (561.5 nm) compared to the parental strain
(560.7 nm) (Fig. 1B). This bathochromic e¡ect was
also observed in room temperature experiments in
which the suppressor strain exhibited a maximum
absorbance for bL at 566.1 nm, instead of 565.1 nm
observed in the wild type strain (data not shown).
We have seen that replacement of the totally con-
served residue glycine 131 by serine prevents both the
insertion of heme bL and the assembly of the bc1
complex [42]. The above results show that the sup-
pressor mutation G260A, in the ef loop, restores the
insertion of heme bL ; however, the suppressor strain
G131S+G260A presents di¡erent characteristics,
namely a red shift of about 1 nm of this heme that
is obviously due to the presence of the serine in po-
sition 131, located only 3 Aî from heme bL (Fig. 5).
3.4. Optical potentiometric redox titrations of the
b and c type hemes in the suppressor and
wild type strains
Data provided in Fig. 2A could be ¢t with a single
n = 1 component with a redox midpoint potential of
+240 mV for cytochromes c+c1 in wild type mito-
chondria, suggesting that cytochromes c and c1 ex-
hibit similar midpoint potentials. This value is in
agreement with those found by both Nelson et al.
[47] for the bovine cyt c1 and Tsai et al. [48] for
the yeast cyt c1 (+232 mV and +268 mV, respec-
tively). No di¡erences were observed between the
suppressor and wild type strains for cyt c+c1. Con-
cerning cyt b (Fig. 2B), redox titrations exhibited a
typical curve well ¢t with two n = 1 components, one
with a low midpoint potential (bL) and a maximum
absorption centered at 565 nm which contributes to
40% of the total absorbance, and the other with a
higher midpoint potential (bH) centered at 562 nm,
which contributes to about 60% of the total absor-
bance. In the case of the G131S+G260A revertant,
the Em;7 for heme bL was found to be slightly higher
(336 mV) than that of the wild type (354 mV) (Fig.
2B). No change was observed in the midpoint poten-
tial of heme bH (about 120 mV in both the revertant
and wild type strains).
3.5. Kinetics of cyt b and cyt c1 reduction in the
suppressor and wild type strains
According to the Q cycle mechanism [4^6], cyt b
Fig. 1. Optical spectra of hemes bH and bL at liquid nitrogen
temperature in the wild type and suppressor G131S+G260A
strains. Mitochondria were suspended in MR3 bu¡er at 3.1 mg/
ml and 4.2 mg/ml for the wild type (solid line) and suppressor
(dashed line) strains, respectively. (A) Heme bH was obtained
from the absorbance di¡erence spectra between succinate re-
duced and ascorbate reduced mitochondria. (B) Heme bL was
obtained from the absorbance di¡erence spectra of succinate+
ascorbate+antimycin minus succinate+ascorbate reduced mito-
chondria [70].
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can be reduced either by the center P pathway (in the
presence of center N inhibitors) or by the thermody-
namically unfavorable center N pathway (in the pres-
ence of center P inhibitors). In order to investigate
which step is modi¢ed in the overall steady-state elec-
tron transfer from ubiquinol to cytochrome c in the
revertant strain, we performed reduction kinetics of
both cyt b and cyt c1 (Fig. 3). These kinetics provide
a global value for (1) the rate of arrival and binding
of the substrate to its site, (2) the rate of the various
electron transfer steps occurring between this binding
site and cytochrome b or c1. The measurements of
these reduction kinetics, however, are limited by the
lag time of the apparatus, which is of the same order
of magnitude as the reduction rate obtained from
experiments on the wild type strain. We therefore
cannot rule out the possibility that, when the mu-
tated strain exhibits the same reduction kinetic as
the parental strain, the corresponding mutation has
some e¡ect. Traces presented in Fig. 3 follow appar-
ent ¢rst order kinetics and a rate constant was calcu-
lated from these kinetics. The percentage of substrate
reduction compared to total dithionite reduction of
the cytochromes was also informative for the ¢nal
level of their reduction in the mutant strain as com-
pared to the wild type strain. Reduction of cyt b by
the center N pathway was found to be una¡ected in
the revertant compared to the wild type strain (Fig.
3A), whereas the reduction kinetics of both cyt c+c1,
and cyt b through center P, were found to be a¡ected
in the revertant strain G131S+G260A (Fig. 3B,C).
The cyt b reduction kinetics through center P, which
exhibited an apparent ¢rst order rate constant, de-
creased by at least 60% compared to the wild type
strain and the level of substrate reducible cyt b as
compared to the total dithionite reducible cyt b is
diminished by 30% (46% in the revertant versus
76% in the wild type strain, results not shown).
Fig. 3C shows that the reduction kinetics of the
high potential pathway (involving both the FeS
Fig. 3. Reduction kinetics of cyt b via the center N and center
P pathways and reduction kinetics of cyt c1 in the wild type
and suppressor G131S+G260A strains. (A) Cyt b reduction ki-
netics via center N (in the presence of the center P inhibitor
myxothiazol). NADH (2 mM) was used as substrate (S) to ini-
tiate cyt reduction. (B) Cyt b reduction kinetics via center P (in
the presence of the center N inhibitor antimycin). (C) Cyt c+c1
reduction kinetics (in the presence of KCN). Reactions were
followed at 562/575 nm and 551/540 nm for the cyt b and cyt
c+c1 reductions, respectively. The same amount of substrate re-
ducible cyt b (A,B) or cyt c+c1 (C) was present in the wild type
and suppressor strains in each experiment.
Fig. 2. Redox midpoint potentials of the components of cyt bc1
complex in mitochondria from the wild type and suppressor
G131S+G260A strains. Mitochondria were suspended at a con-
centration of 4 mg/ml in 50 mM MOPS bu¡er pH 7 and the
experiments were performed as described in Section 2. (A) Cyt
c+c1 redox titration was carried out using the amplitude of the
K band at 551 nm as a function of the ambient redox potential
and the data were ¢t with the Nernst equation for one n = 1
component. Midpoint potential values obtained for the WT (b)
and suppressor strains (a) (+240 mV) are indicated in the ¢g-
ure. (B) Cyt b redox titration was carried out using the ampli-
tude of the K band at 563 nm and the data were ¢t with the
Nernst equation for two n = 1 components. bL midpoint poten-
tial values obtained for the WT and suppressor strains (354
and 336 mV, respectively), and the bH midpoint potential
(+120 mV for both strains) are indicated in the ¢gure.
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Rieske protein and cyt c1) by the ¢rst electron from
the QP bound quinol was also diminished by more
than 60% in the revertant strain compared to the
wild type one. The level of cyt c+c1 reduction de-
creased by only 10% (84% in the suppressor versus
93% in the wild type strain) at the end of the reduc-
tion.
These results show that the revertant strain is af-
fected in the electron transfer steps at the QP site of
the bc1 complex.
3.6. Catalytic e⁄ciency and inhibitor binding at the
QP site
The bc1 complex steady-state activity has been de-
scribed as a ping-pong mechanism in which ubiqui-
nol and cyt c interact with two independent sites. In
order to determine the apparent second order rate
constant (kmin) that characterizes the arrival and
binding of the substrate to its site [49,50], we per-
formed steady-state DBH2-cyt c reductase activities
by varying the concentration of the reducing sub-
strate DBH2 while maintaining the other substrate,
the soluble horse heart cyt c, at saturating levels. The
constant kmin (Table 3) can be calculated from the
ratio of maximal turnover to apparent Km (it should
be borne in mind that the Km is a complex parameter
in the ping-pong mechanism). For the revertant
strain, the kmin was found to be 14 times lower
than for the wild type strain (1.86U106 versus
26.8U106 M31 s31), which indicates that the kinetic
interaction of ubiquinol with the bc1 complex QP site
is a¡ected. As the binding site for ubiquinol is sup-
posed to at least overlap with those of certain inhib-
itors such as myxothiazol and stigmatellin, within a
buried and hydrophobic region of cyt b [51], we sub-
sequently measured the I50 inhibitor titers for myxo-
thiazol and stigmatellin (concentration of inhibitor
required to reduce the DBH2-cyt c reductase activity
by 50%) in both the mutant and wild type strains.
The relative inhibitor titer values (Ir50 = I50 mutant/I50
wild type) reveal that the revertant strain exhibited
only a slight resistance towards myxothiazol
(Ir50 = 1.37) and a low sensitivity towards stigmatellin
(Ir50 = 0.54) (Table 3). These data show that, despite
the fact that the quinol interaction at the QP site was
modi¢ed in the revertant strain, the interaction of the
QP inhibitors myxothiazol and stigmatellin with this
site was poorly a¡ected.
3.7. EPR characterization of the QP site occupancy
The QP site occupancy was monitored by EPR
spectroscopy using the characteristic interaction be-
tween the [2Fe^2S] cluster of the FeS Rieske protein
and the quinone/quinol binding at the QP site. It is
well known that a gx signal centered at g = 1.80 is
observed when the Q pool is fully oxidized (Eh
around 200 mV) and that this signal shifts to a lower
gx value of around 1.77 when the Q pool is fully
reduced (Eh around 0 mV) [18,52,53]. A value of
gx = 1.78 is observed when the QP site is occupied
by the chromone inhibitor stigmatellin [54]. When
the QP site is empty, due to either a mutation or
extraction of quinones, the value of the gx signal is
centered at g = 1.76 [18]. Fig. 4A shows that, in the
case of the wild type strain, an EPR spectrum (typ-
ical of the presence of the FeS Rieske protein) was
obtained when the sample was reduced with ascor-
bate: a gy peak at g = 1.90 and a gx trough centered
Table 3
Catalytic properties of the bc1 complex with the substrate DBH2 (Vmax, Km, kmin) and resistance to inhibitors myxothiazol and stigma-
tellin in the wild type and revertant strains
Strains Vmax (s31) Km DBH2 (M) kmin = Vmax/Km( M31 s31) Ir50 for myxothiazol I
r
50 for stigmatellin
Wild type (KM91) 62.9 2.35U1036 26.8U106 1 1
G131S+G260A 6.45 3.45U1036 1.86U106 1.37 0.54
Vmax represents the maximum DBH2-cyt c reductase activity (mol cyt c reduced s31/mol cyt b) measured at 550/540 nm with a dual
wavelength spectrophotometer. Km for DBH2 was deduced from the titration of the cyt c reductase activity with increasing amounts
of the substrate DBH2 and plotted with a Lineweaver^Burk representation (not shown). kmin (Vmax/Km) represents the enzyme cata-
lytic e⁄ciency for the substrate. The inhibitor titers I50 (concentration of inhibitor required to reduce the DBH2-cyt c reductase activ-
ity by 50%) were 0.84 mol myxothiazol/mol cyt b and 0.38 mol stigmatellin/mol cyt b in the wild type strain. The relative inhibitor
titer (Ir50) is the ratio of I50 in the mutated strain relative to that in the wild type strain.
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at g = 1.803. This latter signal is characteristic of a
QP site fully occupied with oxidized quinone. In the
case of the revertant strain G131S+G260A, the am-
plitude of the gy signal was smaller than that of the
wild type strain (Fig. 4A,C), which re£ects a smaller
quantity of EPR detectable FeS protein (about 50%
compared to the wild type); the gx signal was less
pronounced and shifted to a lower value of
gx = 1.789, thus indicating a partially empty QP site
(Fig. 4A). In the case of the original G131S mutant,
almost no gy signal was detected, both with ascor-
bate and dithionite reduced sample (Fig. 4A,B),
which con¢rms that this mutant presents a bc1 com-
plex non-assembly phenotype. When samples were
reduced with dithionite (Fig. 4B), the Q pool was
fully reduced and the gx signal was shifted from
gx = 1.803 to a value of gx = 1.783 in the wild type
strain, thus showing the response of the EPR [2Fe^
2S] cluster gx signal to the redox state of the Q pool.
In the suppressor strain G131S+G260A, the gx signal
shifted less, going from 1.789 to a value of 1.778,
most likely due to the low level of quinone occu-
pancy in the QP site of this revertant strain. This
result is in agreement with the results found in the
previous section, where a low catalytic e⁄ciency for
quinol was found in the suppressor strain with a kmin
that had decreased by more than one order of mag-
nitude (Table 3). However, this revertant was still
able to bind the QP site inhibitor stigmatellin as
shown by a deeper gx trough centered at gx = 1.776
(Fig. 4C). These data are also in accordance with the
inhibitor titration experiments performed on this
strain, which revealed that the suppressor strain
was not resistant to stigmatellin, being in fact slightly
more sensitive to this inhibitor (Table 3).
Taken as a whole, the data indicate that the sup-
pressor mutation G260A restores the assembly of the
bc1 complex compared to the original respiratory
de¢cient mutant G131S. They also imply that the
low steady-state quinol cyt c reductase activity of
the revertant strain is due to an electron transfer
impairment at the level of the QP site, which is at
least partially related to a weaker quinol binding at
the quinol oxidizing site of the bc1 complex where
both cyt b positions G131 and G260 are localized
(see Fig. 5).
4. Discussion
In this study, we addressed the question of
whether an intragenic suppressor mutation at a dis-
tinct position from the original mutation could com-
pensate mutation at the totally conserved position
131 which prevents the assembly of the bc1 complex.
Fig. 4. QP site occupancy probed by EPR spectra of the Rieske
[2Fe^2S] cluster. (A) EPR spectra were recorded after mito-
chondria were reduced with 10 mM ascorbate (Q pool oxidized)
or (B) with a few grains of dithionite (Q pool completely re-
duced). (C) The inhibitor stigmatellin was added at a ¢nal con-
centration of 20 WM. Note that the scale is di¡erent (U2) for
the revertant G131S+G260A strain. Mitochondrial protein con-
centration was 25, 23 and 29 mg/ml for the wild type strain,
the revertant G131S+G260A and original mutant G131S, re-
spectively. Spectra obtained in the presence of dithionite (B) ex-
hibited a lower gy signal at g = 1.90 due to a negative contribu-
tion of the complex II iron^sulfur clusters. EPR conditions
were as follows: temperature, 15 K; microwave frequency, 9.42
GHz; microwave power, 6.3 mW; modulation frequency, 100
kHz; modulation amplitude, 1.6 milliteslas (mT).
BBABIO 45060 14-8-01 Cyaan Magenta Geel Zwart
G. Brasseur et al. / Biochimica et Biophysica Acta 1506 (2001) 89^102 97
We also examined how such a compensation might
occur. A respiratory competent strain was isolated
from the respiratory de¢cient mutant G131S; the
intragenic suppressor mutation was localized on cyt
b at position 260 where the glycine was replaced by
an alanine, leading to the revertant strain
G131S+G260A. Whereas the original mutant
G131S presented a non-assembled bc1 complex with
less than 25% of total b type cytochromes and no
Core I and Rieske FeS protein, the revertant strain
exhibited an assembled bc1 complex with about 70%
of the b and c type cytochromes and about 50% of
the FeS protein (Table 1 and Fig. 4). The low bc1
complex activity of the revertant strain (about 15%
of wild type enzyme turnover) (Table 2) was enough
to sustain slow growth, indicating that the coupling
between electron transfer and proton translocation
was maintained in this revertant strain. It should
be noted that the cyt b respiratory de¢cient mutant
G131S exhibited less than 10% of the complex II
activity, thus suggesting either a direct and close in-
teraction between complexes II and III and/or a
downregulation of expression of complex II in respi-
ratory de¢cient complex III mutants, as has already
been proposed [37,45,46].
We have seen that, due to their small side chains,
Fig. 5. Model of the cyt b region showing the positions G131 and G260 in the three-dimensional structure of the chicken heart mito-
chondrial bc1 complex. Cyt b G131 (pink) is one of the four conserved glycines involved in heme packing [24] and is located at the
C-terminal part of the transmembrane helix C. The intragenic suppressor mutation G260A (blue colored) is located in the ef loop
(light green) above the amphipathic helix cd1 lying on the top of the membrane. For clarity, only two of the eight transmembrane cyt
b helices of one bc1 complex monomer are depicted, as are the two histidine (His161 and His141 in red) ligands of the [2Fe2S] cluster
of the FeS Rieske protein (gray an yellow balls). Heme bL, which is red shifted in the suppressor strain, and heme bH are colored in
green. The two histidine (His84 and His183, chicken numbering) ligands of heme bL located in helix B and D, respectively, are de-
picted in red. Distances are 13 Aî between G131 and G260, 3 Aî between G131 and heme bL, 8 Aî between G131 and the hydrophobic
tail of the center P inhibitor stigmatellin (CPK colors), and 11 Aî between G260 and the polar head of stigmatellin. The coordinates
of the chicken heart mitochondrial bc1 complex in the presence of the inhibitor stigmatellin were used for this ¢gure (accession No.
3bcc in the Brookhaven Protein Data Bank).
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the four totally conserved glycines G131 and G47, as
well as G117 and G33, allow the correct insertion of
heme bL and heme bH, respectively. Fig. 1 shows that
heme bL was red shifted by about 1 nm in the
G131S+G260A suppressor strain, certainly due to
the presence of the longer and protonated side chain
of serine replacing the smaller amino acid glycine in
position 131, close to heme bL. It is to be noted that
a similar result was obtained in the case of the cyt b
revertant strain G33A isolated from the non-assem-
bly mutant G33D. This suppressor strain [25] exhib-
its a bathochromic e¡ect of 1.5 nm for heme bH [26],
from which the totally conserved G33 is distant by
only 3.5 Aî .
Redox titration experiments showed that the Em;7
of heme bL in the revertant G131S+G260A was
slightly higher (336 mV) than that of the wild type
(354 mV) (Fig. 2B). However, this di¡erence of 18
mV was not considered to be su⁄ciently large to be
the only factor responsible for the low steady-state
ubiquinol-cytochrome c reductase activity in the re-
vertant strain. In this study, the Em;7 values for
hemes bH and bL found for the wild type yeast bc1
complex were similar to those reported for the mito-
chondrial bc1 complex (+19 and +109 mV for bL and
bH, respectively, in yeast complex III [56]; 334 and
+93 mV for bL and bH, respectively, in bovine bc1
complex [47]) and are higher than those found in the
photosynthetic bacterium R. capsulatus [29] (3126
and +71 mV for bL and bH, respectively). Saribas
et al. [29] have shown that rather small and non-
polar amino acid substitutions like alanine and valine
obtained by site directed mutagenesis at the con-
served glycine 146 in R. capsulatus (corresponding
to glycine 131 in S. cerevisiae) a¡ect neither the as-
sembly of the bc1 complex nor the heme bL and bH
midpoint potentials. Thus, it appears that a small
and/or non-polar residue is required to allow correct
heme bL packing. In the suppressor strain
G131S+G260A, no e¡ect was detected on the QN
site; conversely, the kinetics of electron transfer in-
volving the QP site were found to be a¡ected, as was
demonstrated by the slower cyt b and cyt c1 reduc-
tion kinetics by the low and high potential pathways,
respectively (Fig. 3B,C). The decreased kmin (Table 3)
as well as the EPR results (which showed that the
revertant strain exhibited a partially empty QP site
(Fig. 4)), suggest a modi¢ed interaction of the sub-
strate quinol at the QP site. The response to the re-
dox state of the quinol pool was therefore weak in
the revertant strain. These data show that the quinol/
quinone interaction in the bc1 complex of the rever-
tant strain was modi¢ed and might at least partially
explain the slower cyt b and c1 reduction kinetics and
the low steady-state DBH2-cyt c reductase activity
observed in the suppressor strain. Saribas et al. [29]
have shown that alanine and valine substitutions at
glycine 146 in R. capsulatus (G131 in yeast) lead to
an unoccupied QP site. As the suppressor mutation
G260A restored the de¢ciency due to a serine muta-
tion in position 131, it seems likely that the G131S
mutation is directly or indirectly responsible for the
low quinol occupancy at the QP site, probably by
locally modifying the transmembrane helix C (and
then its interaction with heme bL) and thus modify-
ing the quinol binding site. However, it is not possi-
ble to discriminate which of the distal and proximal
quinol/semiquinone binding sites in the Crofts model
[22,51,57] is a¡ected nor is it possible to ascertain
which of the two QOs and QOw quinone binding sites
in the model of Ding et al. [18] is a¡ected. It should
be noted that the stigmatellin binding in the rever-
tant strain was not modi¢ed and no resistance or
sensitivity was found for the QP site inhibitor myxo-
thiazol (Table 3 and Fig. 4C). These data are in
agreement with the distance values between the in-
hibitors and positions G131 and G260 in the three-
dimensional structure of the bc1 complex: glycine
131 and glycine 260 were found to be 6.5 Aî and
10.5 Aî away from the closest atom of the methoxy-
acrylate group of myxothiazol, respectively. Con-
cerning stigmatellin, an inhibitor of the chromone
family [58], glycine 131 was found to be at 8.1 Aî
from the closest atom in the inhibitor hydrophobic
alkenyl tail and glycine 260 is at 11 Aî from the clos-
est atom in the dimethoxyhydroxychromone system
of the stigmatellin polar head (Fig. 5). Thus, our
results show that mutations at positions 131 and
260 are not involved in the stigmatellin and myxo-
thiazol binding domains, but mutation G131S modi-
¢es quinol binding. This suggests that the quinol and
stigmatellin binding domains are not strictly identi-
cal. The modi¢ed region of the quinol binding do-
main probably does not belong to the shared volume
by stigmatellin and myxothiazol, which is located in
the more buried region of cyt b where both the hy-
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drophobic tails of the inhibitors are found [11,51].
The e¡ect seen on the kmin and the EPR spectra
for quinol binding may be due to either an indirect
e¡ect linked to a structural modi¢cation of the ef
loop (which includes position 260), thus leading to
an impairment of the catalytic oxidation of ubiquinol
by the FeS protein when this latter protein is in the
proximal position close to cyt b, in contact with the
ef loop, or to a repositioning of the transmembrane
helix C to accommodate the serine in position 131,
with a subsequent e¡ect on quinol binding. Saribas et
al. [29] reported that G146A,V mutations impaired
the cyt b and c1 reduction kinetics by the QP site,
which is unoccupied by quinol/quinone, whereas stig-
matellin binding was not a¡ected in these mutants, as
was observed in the present study. The EPR gz signal
of heme bL was modi¢ed in these mutants, indicating
that an increase in the size of the amino acid side
chain at position 146 (131 in yeast) perturbs the spa-
tial conformation of heme bL. In the same way, op-
tical spectra have revealed a perturbation of heme
bL, the absorption maximum of which is red shifted
in the revertant.
Analyzing the theoretically possible substitutions
at position 131, it was not possible, from the original
G131S mutant, to obtain reversions with small and
non-polar amino acids such as alanine or valine by a
single base substitution. Only charged amino acids or
those bigger than serine could have been obtained by
a single base change; however, they likely induce a
non-assembly of the complex and thus the non-selec-
tion of these revertants on respiratory substrates.
The suppressor mutation at position 260 was found
with a low reversion frequency (about 1039), still
higher, however, than the frequency of a double
base mutation necessary to obtain an alanine or va-
line in position 131. In the bc1 complex structure,
modeling mutation G131S revealed that amino acids
with long side chains cannot be tolerated at position
131 (in pink in Fig. 5) and would clash with either
heme bL, which is located only 3 Aî away, or the cyt
bL histidine ligand 183 (in red), which is located only
2.5 Aî from the conserved glycine. Surprisingly, anal-
ysis of the initial and suppressor mutations in the
three-dimensional structure of the bc1 complex (Fig.
5) showed that the suppressor mutation was located
far from both the initial mutation (13 Aî from G131)
and heme bL. This long distance interaction cannot
be explained in the context of the dimeric bc1 com-
plex as the distance between the original mutation, in
one monomer, and the suppressor mutation, in the
other monomer, was greater than 25 Aî . It has been
suggested that a movement of the head domain of
the FeS Rieske protein is involved in rapid electron
transfer by domain movement [8^11,22]. In the b
state, the ef loop is in contact with the FeS protein.
Modifying the ef loop could therefore change both
the docking surface with the Rieske protein [22] and,
as a result, the quinol oxidation at the QP site. This
may explain the quinol binding de¢ciency observed
in the revertant strain.
In previous reports, intragenic and extragenic sup-
pressor mutations have been described and studied in
yeast ([25,26,32,35,37,38,45,59^63,71] and R. capsula-
tus [12,64,65] bc1 complexes (see [66] for review) and
analyses of mutant/revertant pairs have been used to
tentatively propose a topology of the protein. It
should be stressed that obtaining second site suppres-
sor mutations can lead to unexpected results, which
are always functionally relevant because they are
‘naturally’ selected. However, it should also be kept
in mind that suppressor mutations do not always
reveal proximal interactions. Knowing the structure
of the bc1 complex, we analyzed the localization of
several intragenic suppressor mutations of the yeast
bc1 complex and found that in some cases, although
the reversion is distant in the sequence from the orig-
inal mutation, both positions are found to be in close
proximity within the structure (for example the cyt b
G137E original mutation and its reversion N256K
are only 3.4 Aî apart, C133Y and I176S are separated
by only 4 Aî ). Conversely, examples of long distance
interactions of up to 46 Aî between cyt b, cyt c1 and
the FeS protein were found in R. capsulatus [64].
Similarly, more than 20 Aî separates the cluster and
the tether regions of the FeS protein in the mutant/
revertant pairs described in [12]. In the bacterial re-
action center, suppressor mutations have been ob-
tained and have revealed long distance interactions
[67,68]. In the same way, long distance interactions
have been found to occur in the transmembrane sub-
unit I of cytochrome oxidase in S. cerevisiae [69].
Glycine is totally conserved in position 131, thus
allowing (1) the insertion of heme bL, (2) the posi-
tioning of the adjacent highly conserved Tyr 132 in-
volved in electron transfer [65], and (3) the position-
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ing of bL heme ligand His 183. Interestingly, glycine
260 is only found in S. cerevisiae. Indeed, it is re-
placed by a valine in protozoa and an alanine is
naturally present in all other organisms, as it is in
subunit IV of the b6f complex [55]. A methyl group
in position 260 (glycine to alanine) is thus su⁄cient
to allow the assembly of the G131S mutant bc1 com-
plex in S. cerevisiae. Indeed, in the bc1 complex
structures, the side chain of alanine 260 in the ef
loop faces the amphipathic helix cd1 (Fig. 5) and is
located 3.4 Aî from the closest atom of G137, 4 Aî
from W136 (Y136 in yeast) and 3.6 Aî from F141
(H141 in yeast), all of which belong to the cd1 helix.
It is thus possible that an additional methyl group in
position 260 displaces the cd1 helix, and consequently
the transmembrane helix C, to create a volume nec-
essary for both the positioning of the serine side
chain in position 131 and the insertion of heme bL.
In conclusion, this study reveals a long distance
interaction in the bc1 complex between an intramem-
brane helix and an intermembrane loop of cyt b.
Despite the fact that glycine 131 is one of the four
totally conserved glycines, and that it is packed in
the membrane against both heme bL and the histi-
dine coordinating this heme, this study shows that it
is possible to ¢nd a suppressor mutation at a long
distance (13 Aî ) from the original mutation, in a non-
membranous part of cyt b. This suggests subtle func-
tional modi¢cations at the QP site that are di⁄cult to
predict through a mere analysis of the bc1 complex
structure. Moreover, it is noteworthy that the only
suppressor mutation found from this G131S mutant
is a long distance reversion. Indeed, neither same site
reversions at position 131 nor proximal second site
suppressor mutations were obtained in the case of
the G131S mutant, as is usually the case in the study
of other couple mutants/revertants.
In a more general way, this study shows that a
slight modi¢cation at a non-critical position
(G260A) may induce a succession of slightly modi-
¢ed interactions between closely related residues,
leading to an important change at a critical and dis-
tal residue (G131).
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